There are several types of breast cancer, luminal-like (luminal A and luminal B subtypes), characterized by the expression of estrogen (ER) and progesterone (PR) receptors, and basal-like breast cancer, characterized by the absence of ER, PR and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.